187 related articles for article (PubMed ID: 15048609)
1. Reduction of clozapine-induced hypersalivation by pirenzepine is safe.
Schneider B; Weigmann H; Hiemke C; Weber B; Fritze J
Pharmacopsychiatry; 2004 Mar; 37(2):43-5. PubMed ID: 15048609
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effect of pirenzepine for clozapine-induced hypersalivation: a randomized, double-blind, placebo-controlled, cross-over study.
Bai YM; Lin CC; Chen JY; Liu WC
J Clin Psychopharmacol; 2001 Dec; 21(6):608-11. PubMed ID: 11763010
[TBL] [Abstract][Full Text] [Related]
3. Pirenzepine for clozapine-induced hypersalivation.
Fritze J; Elliger T
Lancet; 1995 Oct; 346(8981):1034. PubMed ID: 7475564
[No Abstract] [Full Text] [Related]
4. Trihexyphenidyl treatment of clozapine-induced hypersalivation.
Spivak B; Adlersberg S; Rosen L; Gonen N; Mester R; Weizman A
Int Clin Psychopharmacol; 1997 Jul; 12(4):213-5. PubMed ID: 9347382
[TBL] [Abstract][Full Text] [Related]
5. Hyoscine for clozapine-induced hypersalivation: a double-blind, randomized, placebo-controlled cross-over trial.
Segev A; Evans A; Hodsoll J; Whiskey E; Sheriff RS; Shergill S; MacCabe JH
Int Clin Psychopharmacol; 2019 Mar; 34(2):101-107. PubMed ID: 30614850
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of the repeated administration of scopolamine ointment on clozapine-induced hypersalivation in patients with treatment-resistant schizophrenia: A preliminary study.
Takeuchi I; Hanya M; Uno J; Fujita K; Kamei H
Asia Pac Psychiatry; 2017 Dec; 9(4):. PubMed ID: 29193710
[TBL] [Abstract][Full Text] [Related]
7. Sulpiride addition for the treatment of clozapine-induced hypersalivation: preliminary study.
Kreinin A; Epshtein S; Sheinkman A; Tell E
Isr J Psychiatry Relat Sci; 2005; 42(1):61-3. PubMed ID: 16134408
[TBL] [Abstract][Full Text] [Related]
8. Monitoring of plasma clozapine levels and its metabolites in refractory schizophrenic patients.
Liu HC; Chang WH; Wei FC; Lin SK; Lin SK; Jann MW
Ther Drug Monit; 1996 Apr; 18(2):200-7. PubMed ID: 8721285
[TBL] [Abstract][Full Text] [Related]
9. Anticholinergic medication for non-clozapine neuroleptic-induced hypersalivation in people with schizophrenia.
Essali A; Rihawi A; Altujjar M; Alhafez B; Tarboush A; Alhaj Hasan N
Cochrane Database Syst Rev; 2013 Dec; (12):CD009546. PubMed ID: 24353163
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the efficacy and impact on cognition of glycopyrrolate and biperiden for clozapine-induced sialorrhea in schizophrenic patients: a randomized, double-blind, crossover study.
Liang CS; Ho PS; Shen LJ; Lee WK; Yang FW; Chiang KT
Schizophr Res; 2010 Jun; 119(1-3):138-44. PubMed ID: 20299191
[TBL] [Abstract][Full Text] [Related]
11. Clozapine-induced hypersalivation.
Davydov L; Botts SR
Ann Pharmacother; 2000 May; 34(5):662-5. PubMed ID: 10852096
[TBL] [Abstract][Full Text] [Related]
12. Glycopyrrolate in comparison to hyoscine hydrobromide and placebo in the treatment of hypersalivation induced by clozapine (GOTHIC1): study protocol for a randomised controlled feasibility study.
Qurashi I; Chu S; Husain N; Drake RJ; Chaudhry I; Deakin JF
Trials; 2016 Nov; 17(1):553. PubMed ID: 27871302
[TBL] [Abstract][Full Text] [Related]
13. Potential use of ipatropium bromide for the treatment of clozapine-induced hypersalivation: a preliminary report.
Calderon J; Rubin E; Sobota WL
Int Clin Psychopharmacol; 2000 Jan; 15(1):49-52. PubMed ID: 10836287
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacological strategies for clozapine-induced hypersalivation: treatment with botulinum toxin B in one patient and review of the literature].
Kahl KG; Trillenberg P; Kordon A; Lencer R; Klein C; Hagenah J
Nervenarzt; 2005 Feb; 76(2):205-8. PubMed ID: 15448913
[TBL] [Abstract][Full Text] [Related]
15. Double-Blind, Randomized, Placebo-Controlled Trial of Metoclopramide for Hypersalivation Associated With Clozapine.
Kreinin A; Miodownik C; Mirkin V; Gaiduk Y; Yankovsky Y; Bersudsky Y; Lerner PP; Bergman J; Lerner V
J Clin Psychopharmacol; 2016 Jun; 36(3):200-5. PubMed ID: 27028980
[TBL] [Abstract][Full Text] [Related]
16. Moclobemide treatment of clozapine-induced hypersalivation: pilot open study.
Kreinin A; Miodownik C; Libov I; Shestakova D; Lerner V
Clin Neuropharmacol; 2009; 32(3):151-3. PubMed ID: 19483481
[TBL] [Abstract][Full Text] [Related]
17. The effect of sublingual atropine sulfate on clozapine-induced hypersalivation: a multicentre, randomised placebo-controlled trial.
Mubaslat O; Lambert T
Psychopharmacology (Berl); 2020 Oct; 237(10):2905-2915. PubMed ID: 32876732
[TBL] [Abstract][Full Text] [Related]
18. [The clozapine-induced hypersalivation and its treatment].
Soler Roibal MA; Oca Bravo L; Montejo Iglesias LM
Actas Esp Psiquiatr; 1999; 27(6):408-11. PubMed ID: 10611565
[TBL] [Abstract][Full Text] [Related]
19. Clozapine-induced hypersalivation and the alpha 2 adrenoceptor.
Corrigan FM; MacDonald S; Reynolds GP
Br J Psychiatry; 1995 Sep; 167(3):412. PubMed ID: 7496663
[No Abstract] [Full Text] [Related]
20. Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics.
Spina E; Avenoso A; Facciolà G; Scordo MG; Ancione M; Madia AG; Ventimiglia A; Perucca E
Psychopharmacology (Berl); 2000 Jan; 148(1):83-9. PubMed ID: 10663421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
